Interleukin-27 levels in patients with myasthenia gravis.

Interleukin-27 levels in patients with myasthenia gravis.
复制标题

重症肌无力患者的白细胞介素 27 水平。

DOI:
10.1515/tnsci-2020-0134
复制
发表时间:
2020
影响因子:
2.1
通讯作者:
Yang L
Yang L
中科院分区:
医学4区
文献类型:
--
作者:
Liu XJ;Zhang LJ;Yi M;Li LM;Wang J;Qi Y;Zhao P;Zhang DQ;Yang L

文献摘要

相似文献

白细胞介素-27(IL-27)属于IL-12家族,通过调节叉头框P3(FoxP 3)的表达和功能影响T细胞的功能。本研究检测了59例重症肌无力(MG)患者和35例健康对照者(HC)血清IL-27水平。其中32例MG患者接受静脉注射免疫球蛋白(IVIG)(0.4 g/kg/d,连续5 d)。在治疗前后收集IL-27水平并进行比较研究。最后,我们评估了IL-27水平与MG临床特征的相关性。结果表明,MG患者血清IL-27水平显著高于HC患者。同时,IVIG治疗后检测到显著降低。IL-27水平与MG日常生活活动和定量MG评分呈正相关。IL-27可能参与了MG的发病过程,可作为MG的早期诊断和预后判断的指标。此外,IL-27可通过调节特异性免疫信号传导和维持免疫稳态而用作MG治疗的靶点。
Interleukin-27 (IL-27), which belongs to IL-12 family, influences the function of T cells (Tregs) through regulating the expression, and function of forkhead box P3 (FoxP3). In this study, we detected the IL-27 serum levels in 59 myasthenia gravis (MG) patients and 35 healthy controls (HCs). Among them, 32 MG patients received immunoglobulin intravenous (IVIG) injections (0.4 g/kg per day for 5 consecutive days). IL-27 levels were collected before and after the treatments and subjected to a comparative study. Finally, we assessed the correlations of IL-27 levels with the clinical characteristics of MG. As a result, serum IL-27 levels were significantly higher in MG patients than those in the HCs. Meanwhile, significant reduction was detected after the IVIG treatment. IL-27 levels positively correlated with both MG activities of daily living and quantitative MG score. IL-27 may participate in the pathogenesis of MG and can be used as an early marker for the diagnosis and prognosis of MG. In addition, IL-27 can be used as a target for MG treatment through the regulation of specific immune signaling and maintaining immune homeostasis.